Download original image
Fig. 1. The risk for developing acute rejection (A) and chronic kidney disease (CKD) (B). TAC, tacrolimus; EVR-TAC, combination of everolimus and reduced tacrolimus; DDLT, deceased donor liver transplantation.
Korean J Transplant 2021;35:8~14 https://doi.org/10.4285/kjt.20.0043
© Korean Journal of Transplantation